Filing Details

Accession Number:
0001144204-17-064730
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-21 14:01:45
Reporting Period:
2017-12-13
Accepted Time:
2017-12-21 14:01:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385508 Opiant Pharmaceuticals Inc. OPNT Metal Mining (1000) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657053 Geoffrey Wolf Unit 10, Level 11
Sharjah Media City C0
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.001 Par Value Per Share Disposition 2017-12-13 7,804 $29.61 100,771 No 4 S Direct
Common Stock, $.001 Par Value Per Share Disposition 2017-12-18 27,134 $20.68 73,637 No 4 S Direct
Common Stock, $.001 Par Value Per Share Acquisiton 2017-12-19 37,860 $15.00 111,497 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Disposition 2017-12-19 37,850 $0.00 37,850 $15.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
277,150 2017-09-01 2017-12-31 No 4 C Direct
Footnotes
  1. This Form 4 is a late filing reporting the changes in beneficial ownership of the Reporting Person as of December 19, 2017. This Form 4 was required to be filed within two business days of 12/13/2017, the date the Reporting Person sold shares.
  2. These Warrants could only be exercised between the following dates: (i) the earliest date on which the price per Share has traded at or above US$ 30.00 for at least three trading days out of any ten (10) consecutive trading days; and (ii) the Expiration Date (December 31, 2017). These Warrants became exercisable on September 1, 2017.